{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:53:48Z","timestamp":1789610028045,"version":"build-2803163510"},"reference-count":182,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T00:00:00Z","timestamp":1654819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T00:00:00Z","timestamp":1654819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-17-1-0292"],"award-info":[{"award-number":["W81XWH-17-1-0292"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-17-1-0286"],"award-info":[{"award-number":["W81XWH-17-1-0286"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000892","name":"Prostate Cancer Foundation","doi-asserted-by":"publisher","award":["19CHAS03"],"award-info":[{"award-number":["19CHAS03"]}],"id":[{"id":"10.13039\/100000892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000892","name":"Prostate Cancer Foundation","doi-asserted-by":"publisher","award":["19CHAS03"],"award-info":[{"award-number":["19CHAS03"]}],"id":[{"id":"10.13039\/100000892","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Purinergic Signalling"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s11302-022-09875-1","type":"journal-article","created":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T05:04:01Z","timestamp":1654837441000},"page":"267-287","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["P2 purinergic receptor dysregulation in urologic disease"],"prefix":"10.1007","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0448-8552","authenticated-orcid":false,"given":"Janielle P.","family":"Maynard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen S.","family":"Sfanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,10]]},"reference":[{"key":"9875_CR1","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/bies.201100130","volume":"34","author":"G Burnstock","year":"2012","unstructured":"Burnstock G (2012) Purinergic signalling: its unpopular beginning, its acceptance and its exciting future. BioEssays 34:218\u2013225. https:\/\/doi.org\/10.1002\/bies.201100130","journal-title":"BioEssays"},{"key":"9875_CR2","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0031-6997(25)06930-3","volume":"24","author":"G Burnstock","year":"1972","unstructured":"Burnstock G (1972) Purinergic nerves. Pharmacol Rev 24:509","journal-title":"Pharmacol Rev"},{"key":"9875_CR3","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/nature13085","volume":"509","author":"M Idzko","year":"2014","unstructured":"Idzko M, Ferrari D, Eltzschig HK (2014) Nucleotide signalling during inflammation. Nature 509:310\u2013317. https:\/\/doi.org\/10.1038\/nature13085","journal-title":"Nature"},{"key":"9875_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3389\/fncel.2014.00006","volume":"8","author":"DSK Samways","year":"2014","unstructured":"Samways DSK, Li Z, Egan TM (2014) Principles and properties of ion flow in P2X receptors. Front Cell Neurosci 8:6\u20136. https:\/\/doi.org\/10.3389\/fncel.2014.00006","journal-title":"Front Cell Neurosci"},{"key":"9875_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11302-011-9271-6","volume":"8","author":"AP Ford","year":"2012","unstructured":"Ford AP (2012) In pursuit of P2X3 antagonists: novel therapeutics for chronic pain and afferent sensitization. Purinergic Signal 8:3\u201326. https:\/\/doi.org\/10.1007\/s11302-011-9271-6","journal-title":"Purinergic Signal"},{"key":"9875_CR6","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1124\/jpet.106.105890","volume":"324","author":"D Donnelly-Roberts","year":"2008","unstructured":"Donnelly-Roberts D, McGaraughty S, Shieh C-C, Honore P, Jarvis MF (2008) Painful purinergic receptors. J Pharmacol Exp Ther 324:409\u2013415. https:\/\/doi.org\/10.1124\/jpet.106.105890","journal-title":"J Pharmacol Exp Ther"},{"key":"9875_CR7","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s002100000310","volume":"362","author":"I von K\u00fcgelgen","year":"2000","unstructured":"von K\u00fcgelgen I, Wetter A (2000) Molecular pharmacology of P2Y-receptors. Naunyn Schmiedebergs Arch Pharmacol 362:310\u2013323. https:\/\/doi.org\/10.1007\/s002100000310","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"9875_CR8","first-page":"1375","volume":"78","author":"GR Somers","year":"1998","unstructured":"Somers GR, Hammet FM, Trute L, Southey MC, Venter DJ (1998) Expression of the PY purinergic receptor in human T cells infiltrating inflammatory bowel disease. Lab Investig; J Tech Methods Pathol 78:1375\u20131383","journal-title":"Lab Investig; J Tech Methods Pathol"},{"key":"9875_CR9","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0303-7207(03)00003-0","volume":"204","author":"R Coutinho-Silva","year":"2003","unstructured":"Coutinho-Silva R, Parsons M, Robson T, Lincoln J, Burnstock G (2003) P2X and P2Y purinoceptor expression in pancreas from streptozotocin-diabetic rats. Mol Cell Endocrinol 204:141\u2013154. https:\/\/doi.org\/10.1016\/S0303-7207(03)00003-0","journal-title":"Mol Cell Endocrinol"},{"key":"9875_CR10","doi-asserted-by":"publisher","first-page":"3799","DOI":"10.1097\/00001756-200011270-00041","volume":"11","author":"D Moore","year":"2000","unstructured":"Moore D, Iritani S, Chambers J, Emson P (2000) Immunohistochemical localization of the P2Y1 purinergic receptor in Alzheimer\u2019s disease. NeuroReport 11:3799\u20133803. https:\/\/doi.org\/10.1097\/00001756-200011270-00041","journal-title":"NeuroReport"},{"key":"9875_CR11","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.0309-0167.2004.01798.x","volume":"44","author":"M Slater","year":"2004","unstructured":"Slater M, Danieletto S, Gidley-Baird A, Teh LC, Barden JA (2004) Early prostate cancer detected using expression of non-functional cytolytic P2X7 receptors. Histopathology 44:206\u2013215. https:\/\/doi.org\/10.1111\/j.0309-0167.2004.01798.x","journal-title":"Histopathology"},{"key":"9875_CR12","doi-asserted-by":"publisher","unstructured":"Mihai S, Codrici E, Popescu ID, Enciu A-M, Albulescu L, Necula LG, Mambet C, Anton G, Tanase C (2018) Inflammation-related mechanisms in chronic kidney disease prediction, progression, and outcome. J Immunol Res\u00a02018:2180373. https:\/\/doi.org\/10.1155\/2018\/2180373","DOI":"10.1155\/2018\/2180373"},{"key":"9875_CR13","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1055\/s-0038-1676089","volume":"36","author":"I Marcu","year":"2018","unstructured":"Marcu I, Campian EC, Tu FF (2018) Interstitial cystitis\/bladder pain syndrome. Sem Reprod Med 36:123\u2013135. https:\/\/doi.org\/10.1055\/s-0038-1676089","journal-title":"Sem Reprod Med"},{"key":"9875_CR14","doi-asserted-by":"publisher","first-page":"F805","DOI":"10.1152\/ajprenal.00339.2015","volume":"311","author":"A Contreras-Sanz","year":"2016","unstructured":"Contreras-Sanz A, Krska L, Balachandran AA, Curtiss NL, Khasriya R, Kelley S, Strutt M, Gill HS, Taylor KM, Mansfield KJ, Wu C, Peppiatt-Wildman CM, Malone-Lee J, Duckett J, Wildman SS (2016) Altered urothelial ATP signaling in a major subset of human overactive bladder patients with pyuria. Am J Physiol Renal Physiol 311:F805\u2013F816. https:\/\/doi.org\/10.1152\/ajprenal.00339.2015","journal-title":"Am J Physiol Renal Physiol"},{"key":"9875_CR15","doi-asserted-by":"crossref","unstructured":"Krieger JN, Nyberg J, Leroy and Nickel JC (1999) NIH consensus definition and classification of prostatitis. JAMA 282 236\u2013237 10\u20131001\/pubs.JAMA-ISSN-0098\u20137484\u2013282\u20133-jac90006","DOI":"10.1001\/jama.282.3.236"},{"key":"9875_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ucl.2016.04.001","volume":"43","author":"KB Egan","year":"2016","unstructured":"Egan KB (2016) The epidemiology of benign prostatic hyperplasia associated with lower urinary tract symptoms: prevalence and incident rates. Urol Clin North Am 43:289\u2013297. https:\/\/doi.org\/10.1016\/j.ucl.2016.04.001","journal-title":"Urol Clin North Am"},{"key":"9875_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrurol.2017.167","volume":"15","author":"KS Sfanos","year":"2018","unstructured":"Sfanos KS, Yegnasubramanian S, Nelson WG, De Marzo AM (2018) The inflammatory microenvironment and microbiome in prostate cancer development. Nat Rev Urol 15:11\u201324. https:\/\/doi.org\/10.1038\/nrurol.2017.167","journal-title":"Nat Rev Urol"},{"key":"9875_CR18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/978-3-0348-0837-8_9","volume":"816","author":"AR de Vivar Chevez","year":"2014","unstructured":"de Vivar Chevez AR, Finke J, Bukowski R (2014) The role of inflammation in kidney cancer. Adv Exp Med Biol 816:197\u2013234. https:\/\/doi.org\/10.1007\/978-3-0348-0837-8_9","journal-title":"Adv Exp Med Biol"},{"key":"9875_CR19","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/978-3-0348-0837-8_8","volume":"816","author":"G Gakis","year":"2014","unstructured":"Gakis G (2014) The role of inflammation in bladder cancer. Adv Exp Med Biol 816:183\u2013196. https:\/\/doi.org\/10.1007\/978-3-0348-0837-8_8","journal-title":"Adv Exp Med Biol"},{"key":"9875_CR20","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1146\/annurev.iy.12.040194.005015","volume":"12","author":"P Matzinger","year":"1994","unstructured":"Matzinger P (1994) Tolerance, danger, and the extended family. Annu Rev Immunol 12:991\u20131045. https:\/\/doi.org\/10.1146\/annurev.iy.12.040194.005015","journal-title":"Annu Rev Immunol"},{"key":"9875_CR21","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.tips.2007.07.002","volume":"28","author":"F Di Virgilio","year":"2007","unstructured":"Di Virgilio F (2007) Liaisons dangereuses: P2X7 and the inflammasome. Trends Pharmacol Sci 28:465\u2013472. https:\/\/doi.org\/10.1016\/j.tips.2007.07.002","journal-title":"Trends Pharmacol Sci"},{"key":"9875_CR22","doi-asserted-by":"publisher","first-page":"20120101","DOI":"10.1098\/rsfs.2012.0101","volume":"3","author":"S Falzoni","year":"2013","unstructured":"Falzoni S, Donvito G, Virgilio FD (2013) Detecting adenosine triphosphate in the pericellular space. Interface Focus 3:20120101. https:\/\/doi.org\/10.1098\/rsfs.2012.0101","journal-title":"Interface Focus"},{"key":"9875_CR23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11302-015-9493-0","volume":"12","author":"G Burnstock","year":"2016","unstructured":"Burnstock G (2016) P2X ion channel receptors and inflammation. Purinergic Signalling 12:59\u201367. https:\/\/doi.org\/10.1007\/s11302-015-9493-0","journal-title":"Purinergic Signalling"},{"key":"9875_CR24","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1124\/pr.117.014878","volume":"71","author":"L Antonioli","year":"2019","unstructured":"Antonioli L, Blandizzi C, Pacher P, Hask\u00f3 G (2019) The purinergic system as a pharmacological target for the treatment of immune-mediated inflammatory diseases. Pharmacol Rev 71:345\u2013382. https:\/\/doi.org\/10.1124\/pr.117.014878","journal-title":"Pharmacol Rev"},{"issue":"2","key":"9875_CR25","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3390\/ijms20020280","volume":"20","author":"F Aielli","year":"2019","unstructured":"Aielli F, Ponzetti M, Rucci N (2019) Bone metastasis pain, from the bench to the bedside. Int J Mol Sci 20(2):280. https:\/\/doi.org\/10.3390\/ijms20020280","journal-title":"Int J Mol Sci"},{"key":"9875_CR26","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/377428a0","volume":"377","author":"C-C Chen","year":"1995","unstructured":"Chen C-C, Akopian AN, Sivilottit L, Colquhoun D, Burnstock G, Wood JN (1995) A P2X purinoceptor expressed by a subset of sensory neurons. Nature 377:428\u2013431. https:\/\/doi.org\/10.1038\/377428a0","journal-title":"Nature"},{"key":"9875_CR27","doi-asserted-by":"publisher","unstructured":"Kaan TK, Yip PK, Patel S, Davies M, Marchand F, Cockayne DA, Nunn PA, Dickenson AH, Ford AP, Zhong Y, Malcangio M, McMahon SB (2010) Systemic blockade of P2X3 and P2X2\/3 receptors attenuates bone cancer pain behaviour in rats. Brain: J Neurol 133:2549\u20132564. https:\/\/doi.org\/10.1093\/brain\/awq194","DOI":"10.1093\/brain\/awq194"},{"key":"9875_CR28","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1046\/j.1523-1755.2002.00315.x","volume":"61","author":"O Vonend","year":"2002","unstructured":"Vonend O, Oberhauser V, Von K\u00fcgelgen I, Apel TW, Amann K, Ritz E, Rump LC (2002) ATP release in human kidney cortex and its mitogenic effects in visceral glomerular epithelial cells. Kidney Int 61:1617\u20131626. https:\/\/doi.org\/10.1046\/j.1523-1755.2002.00315.x","journal-title":"Kidney Int"},{"key":"9875_CR29","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ebiom.2017.04.011","volume":"19","author":"RI Menzies","year":"2017","unstructured":"Menzies RI, Booth JWR, Mullins JJ, Bailey MA, Tam FWK, Norman JT, Unwin RJ (2017) Hyperglycemia-induced renal P2X7 receptor activation enhances diabetes-related injury. EBioMedicine 19:73\u201383. https:\/\/doi.org\/10.1016\/j.ebiom.2017.04.011","journal-title":"EBioMedicine"},{"key":"9875_CR30","doi-asserted-by":"publisher","unstructured":"Craigie E, Menzies RI, Larsen CK, Jacquillet G, Carrel M, Wildman SS, Loffing J, Leipziger J, Shirley DG, Bailey MA, Unwin RJ (2018) The renal and blood pressure response to low sodium diet in P2X4 receptor knockout mice. Physiol Rep 6:e13899. https:\/\/doi.org\/10.14814\/phy2.13899","DOI":"10.14814\/phy2.13899"},{"key":"9875_CR31","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1002\/wmts.61","volume":"1","author":"V Vallon","year":"2012","unstructured":"Vallon V, Stockand J, Rieg T (2012) P2Y receptors and kidney function. Wiley Interdiscip Rev Memb Trans Signal 1:731\u2013742. https:\/\/doi.org\/10.1002\/wmts.61","journal-title":"Wiley Interdiscip Rev Memb Trans Signal"},{"key":"9875_CR32","doi-asserted-by":"publisher","unstructured":"Rieg T, Bundey RA, Chen Y, Deschenes G, Junger W, Insel PA, Vallon V (2007) Mice lacking P2Y2 receptors have salt-resistant hypertension and facilitated renal Na+ and water reabsorption. Faseb J 21:3717\u20133726. https:\/\/doi.org\/10.1096\/fj.07-8807com","DOI":"10.1096\/fj.07-8807com"},{"key":"9875_CR33","doi-asserted-by":"publisher","first-page":"R510","DOI":"10.1152\/ajpregu.00148.2011","volume":"301","author":"T Rieg","year":"2011","unstructured":"Rieg T, Gerasimova M, Boyer JL, Insel PA, Vallon V (2011) P2Y2 receptor activation decreases blood pressure and increases renal Na+ excretion. Am J Physiol Regul Integr Comp Physiol 301:R510\u2013R518. https:\/\/doi.org\/10.1152\/ajpregu.00148.2011","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"9875_CR34","doi-asserted-by":"publisher","unstructured":"Stokes L, Scurrah K, Ellis Justine A, Cromer Brett A, Skarratt Kristen K, Gu Ben J, Harrap Stephen B, Wiley James S (2011) A loss-of-function polymorphism in the human P2X4 receptor is associated with increased pulse pressure. Hypertension 58:1086\u20131092. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.111.176180","DOI":"10.1161\/HYPERTENSIONAHA.111.176180"},{"key":"9875_CR35","unstructured":"Center for Disease Control and Prevention. Chronic kidney disease surveillance system - United States. http:\/\/www.cdc.gov\/ckd"},{"key":"9875_CR36","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1001\/jama.2019.14745","volume":"322","author":"TK Chen","year":"2019","unstructured":"Chen TK, Knicely DH, Grams ME (2019) Chronic kidney disease diagnosis and management: a review. JAMA 322:1294\u20131304. https:\/\/doi.org\/10.1001\/jama.2019.14745","journal-title":"JAMA"},{"key":"9875_CR37","doi-asserted-by":"publisher","unstructured":"Granata S, Masola V, Zoratti E, Scupoli MT, Baruzzi A, Messa M, Sallustio F, Gesualdo L, Lupo A, Zaza G (2015) NLRP3 inflammasome activation in dialyzed chronic kidney disease patients. PLoS ONE 10:e0122272. https:\/\/doi.org\/10.1371\/journal.pone.0122272","DOI":"10.1371\/journal.pone.0122272"},{"key":"9875_CR38","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1002\/path.4237","volume":"231","author":"A Solini","year":"2013","unstructured":"Solini A, Menini S, Rossi C, Ricci C, Santini E, Blasetti Fantauzzi C, Iacobini C, Pugliese G (2013) The purinergic 2X7 receptor participates in renal inflammation and injury induced by high-fat diet: possible role of NLRP3 inflammasome activation. J Pathol 231:342\u2013353. https:\/\/doi.org\/10.1002\/path.4237","journal-title":"J Pathol"},{"key":"9875_CR39","first-page":"779","volume":"68","author":"I Lajdova","year":"2017","unstructured":"Lajdova I, Oksa A, Horvathova M, Spustova V (2017) Expression of purinergic P2X7 receptors in subpopulations of peripheral blood mononuclear cells in early-stage of chronic kidney disease. J Physiol Pharmacol\u202f: Off J Polish Physiol Soc 68:779\u2013785","journal-title":"J Physiol Pharmacol : Off J Polish Physiol Soc"},{"key":"9875_CR40","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1159\/000330349","volume":"35","author":"I Lajdova","year":"2012","unstructured":"Lajdova I, Oksa A, Chorvat D Jr, Topor P, Spustova V (2012) Purinergic P2X7 receptors participate in disturbed intracellular calcium homeostasis in peripheral blood mononuclear cells of patients with chronic kidney disease. Kidney Blood Press Res 35:48\u201357. https:\/\/doi.org\/10.1159\/000330349","journal-title":"Kidney Blood Press Res"},{"key":"9875_CR41","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3389\/fphys.2013.00234","volume":"4","author":"SA Potthoff","year":"2013","unstructured":"Potthoff SA, Stegbauer J, Becker J, Wagenhaeuser PJ, Duvnjak B, Rump LC, Vonend O (2013) P2Y2 receptor deficiency aggravates chronic kidney disease progression. Front Physiol 4:234. https:\/\/doi.org\/10.3389\/fphys.2013.00234","journal-title":"Front Physiol"},{"key":"9875_CR42","doi-asserted-by":"publisher","first-page":"F293","DOI":"10.1152\/ajprenal.00364.2017","volume":"314","author":"M Rabadi","year":"2018","unstructured":"Rabadi M, Kim M, Li H, Han SJ, Choi Y, D\u2019Agati V, Lee HT (2018) ATP induces PAD4 in renal proximal tubule cells via P2X7 receptor activation to exacerbate ischemic AKI. Am J Physiol Renal Physiol 314:F293\u2013F305. https:\/\/doi.org\/10.1152\/ajprenal.00364.2017","journal-title":"Am J Physiol Renal Physiol"},{"key":"9875_CR43","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.semnephrol.2016.05.005","volume":"36","author":"RK Hsu","year":"2016","unstructured":"Hsu RK, Hsu C-Y (2016) The role of acute kidney injury in chronic kidney disease. Semin Nephrol 36:283\u2013292. https:\/\/doi.org\/10.1016\/j.semnephrol.2016.05.005","journal-title":"Semin Nephrol"},{"key":"9875_CR44","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/ki.2008.107","volume":"74","author":"CY Hsu","year":"2008","unstructured":"Hsu CY, Ordo\u00f1ez JD, Chertow GM, Fan D, McCulloch CE, Go AS (2008) The risk of acute renal failure in patients with chronic kidney disease. Kidney Int 74:101\u2013107. https:\/\/doi.org\/10.1038\/ki.2008.107","journal-title":"Kidney Int"},{"key":"9875_CR45","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/S0140-6736(11)61454-2","volume":"380","author":"R Bellomo","year":"2012","unstructured":"Bellomo R, Kellum JA, Ronco C (2012) Acute kidney injury. Lancet 380:756\u2013766. https:\/\/doi.org\/10.1016\/S0140-6736(11)61454-2","journal-title":"Lancet"},{"key":"9875_CR46","doi-asserted-by":"publisher","first-page":"5465","DOI":"10.1096\/fj.201903287R","volume":"34","author":"SJ Han","year":"2020","unstructured":"Han SJ, Lovaszi M, Kim M, D\u2019Agati V, Hask\u00f3 G, Lee HT (2020) P2X4 receptor exacerbates ischemic AKI and induces renal proximal tubular NLRP3 inflammasome signaling. Faseb J 34:5465\u20135482. https:\/\/doi.org\/10.1096\/fj.201903287R","journal-title":"Faseb J"},{"key":"9875_CR47","doi-asserted-by":"publisher","first-page":"C463","DOI":"10.1152\/ajpcell.00245.2014","volume":"308","author":"Y Yan","year":"2015","unstructured":"Yan Y, Bai J, Zhou X, Tang J, Jiang C, Tolbert E, Bayliss G, Gong R, Zhao TC, Zhuang S (2015) P2X7 receptor inhibition protects against ischemic acute kidney injury in mice. Am J Physiol Cell Physiol 308:C463-472. https:\/\/doi.org\/10.1152\/ajpcell.00245.2014","journal-title":"Am J Physiol Cell Physiol"},{"key":"9875_CR48","doi-asserted-by":"publisher","unstructured":"Battistone MA, Mendelsohn AC, Spallanzani RG, Allegretti AS, Liberman RN, Sesma J, Kalim S, Wall SM, Bonventre JV, Lazarowski ER, Brown D, Breton S(2020) Pro-inflammatory P2Y14 receptor inhibition protects against ischemic acute kidney injury in mice. J Clin Investig. https:\/\/doi.org\/10.1172\/JCI134791","DOI":"10.1172\/JCI134791"},{"key":"9875_CR49","unstructured":"Polycystic kidney disease. U.S. National Library of Medicine (2020)."},{"key":"9875_CR50","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41572-018-0047-y","volume":"4","author":"C Bergmann","year":"2018","unstructured":"Bergmann C, Guay-Woodford LM, Harris PC, Horie S, Peters DJM, Torres VE (2018) Polycystic kidney disease. Nat Rev Dis Primers 4:50\u201350. https:\/\/doi.org\/10.1038\/s41572-018-0047-y","journal-title":"Nat Rev Dis Primers"},{"key":"9875_CR51","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1159\/000082247","volume":"178","author":"CM Turner","year":"2004","unstructured":"Turner CM, Ramesh B, Srai SK, Burnstock G, Unwin RJ (2004) Altered ATP-sensitive P2 receptor subtype expression in the Han:SPRD cy\/+ rat, a model of autosomal dominant polycystic kidney disease. Cells Tissues Organs 178:168\u2013179. https:\/\/doi.org\/10.1159\/000082247","journal-title":"Cells Tissues Organs"},{"key":"9875_CR52","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1681\/asn.2010070728","volume":"22","author":"MY Chang","year":"2011","unstructured":"Chang MY, Lu JK, Tian YC, Chen YC, Hung CC, Huang YH, Chen YH, Wu MS, Yang CW, Cheng YC (2011) Inhibition of the P2X7 receptor reduces cystogenesis in PKD. J Am Soc Nephrol 22:1696\u20131706. https:\/\/doi.org\/10.1681\/asn.2010070728","journal-title":"J Am Soc Nephrol"},{"key":"9875_CR53","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.bbrc.2004.07.148","volume":"322","author":"KA Hillman","year":"2004","unstructured":"Hillman KA, Woolf AS, Johnson TM, Wade A, Unwin RJ, Winyard PJ (2004) The P2X7 ATP receptor modulates renal cyst development in vitro. Biochem Biophys Res Commun 322:434\u2013439. https:\/\/doi.org\/10.1016\/j.bbrc.2004.07.148","journal-title":"Biochem Biophys Res Commun"},{"key":"9875_CR54","doi-asserted-by":"publisher","first-page":"F763","DOI":"10.1152\/ajprenal.0337.2000","volume":"282","author":"EM Schwiebert","year":"2002","unstructured":"Schwiebert EM, Wallace DP, Braunstein GM, King SR, Peti-Peterdi J, Hanaoka K, Guggino WB, Guay-Woodford LM, Bell PD, Sullivan LP, Grantham JJ, Taylor AL (2002) Autocrine extracellular purinergic signaling in epithelial cells derived from polycystic kidneys. Am J Physiol-Renal Physiol 282:F763\u2013F775. https:\/\/doi.org\/10.1152\/ajprenal.0337.2000","journal-title":"Am J Physiol-Renal Physiol"},{"key":"9875_CR55","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1681\/ASN.V102218","volume":"10","author":"PD Wilson","year":"1999","unstructured":"Wilson PD, Hovater JS, Casey CC, Fortenberry JA, Schwiebert EM (1999) ATP release mechanisms in primary cultures of epithelia derived from the cysts of polycystic kidneys. J Am Soc Nephrol 10:218\u2013229","journal-title":"J Am Soc Nephrol"},{"key":"9875_CR56","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s11302-018-9632-5","volume":"14","author":"O Palygin","year":"2018","unstructured":"Palygin O, Ilatovskaya DV, Levchenko V, Klemens CA, Dissanayake L, Williams AM, Pavlov TS, Staruschenko A (2018) Characterization of purinergic receptor expression in ARPKD cystic epithelia. Purinergic Signal 14:485\u2013497. https:\/\/doi.org\/10.1007\/s11302-018-9632-5","journal-title":"Purinergic Signal"},{"key":"9875_CR57","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41585-019-0211-5","volume":"16","author":"WM Linehan","year":"2019","unstructured":"Linehan WM, Ricketts CJ (2019) The cancer genome atlas of renal cell carcinoma: findings and clinical implications. Nat Rev Urol 16:539\u2013552. https:\/\/doi.org\/10.1038\/s41585-019-0211-5","journal-title":"Nat Rev Urol"},{"key":"9875_CR58","unstructured":"Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2014, National Cancer Institute. Bethesda, MD, https:\/\/seer.cancer.gov\/csr\/1975_2014\/, based on November 2016 SEER data submission, posted to the SEER web site, April 2017"},{"key":"9875_CR59","doi-asserted-by":"publisher","first-page":"41162","DOI":"10.18632\/oncotarget.6240","volume":"6","author":"JP Maynard","year":"2015","unstructured":"Maynard JP, Lee J-S, Sohn BH, Yu X, Lopez-Terrada D, Finegold MJ, Goss JA, Thevananther S (2015) P2X3 purinergic receptor overexpression is associated with poor recurrence-free survival in hepatocellular carcinoma patients. Oncotarget 6:41162\u201341179","journal-title":"Oncotarget"},{"key":"9875_CR60","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1474-8673.2007.00389.x","volume":"27","author":"G Nylund","year":"2007","unstructured":"Nylund G, Hultman L, Nordgren S, Delbro DS (2007) P2Y2- and P2Y4 purinergic receptors are over-expressed in human colon cancer. Auton Autacoid Pharmacol 27:79\u201384. https:\/\/doi.org\/10.1111\/j.1474-8673.2007.00389.x","journal-title":"Auton Autacoid Pharmacol"},{"key":"9875_CR61","doi-asserted-by":"publisher","first-page":"G223","DOI":"10.1152\/ajpgi.00259.2006","volume":"292","author":"BM K\u00fcnzli","year":"2007","unstructured":"K\u00fcnzli BM, Berberat PO, Giese T, Csizmadia E, Kaczmarek E, Baker C, Halaceli I, B\u00fcchler MW, Friess H, Robson SC (2007) Upregulation of CD39\/NTPDases and P2 receptors in human pancreatic disease. Am J Physiol - Gastrointest Liver Physiol 292:G223\u2013G230","journal-title":"Am J Physiol - Gastrointest Liver Physiol"},{"key":"9875_CR62","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1111\/cas.12736","volume":"106","author":"Z Liu","year":"2015","unstructured":"Liu Z, Liu Y, Xu L, An H, Chang Y, Yang Y, Zhang W, Xu J (2015) P2X7 receptor predicts postoperative cancer-specific survival of patients with clear-cell renal cell carcinoma. Cancer Sci 106:1224\u20131231. https:\/\/doi.org\/10.1111\/cas.12736","journal-title":"Cancer Sci"},{"key":"9875_CR63","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s13046-019-1223-y","volume":"38","author":"D Gong","year":"2019","unstructured":"Gong D, Zhang J, Chen Y, Xu Y, Ma J, Hu G, Huang Y, Zheng J, Zhai W, Xue W (2019) The m(6)A-suppressed P2RX6 activation promotes renal cancer cells migration and invasion through ATP-induced Ca(2+) influx modulating ERK1\/2 phosphorylation and MMP9 signaling pathway. J Exp Clin Cancer Res: CR 38:233. https:\/\/doi.org\/10.1186\/s13046-019-1223-y","journal-title":"J Exp Clin Cancer Res: CR"},{"key":"9875_CR64","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/1471-2407-9-152","volume":"9","author":"MV Yusenko","year":"2009","unstructured":"Yusenko MV, Kuiper RP, Boethe T, Ljungberg B, van Kessel AG, Kovacs G (2009) High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas. BMC Cancer 9:152. https:\/\/doi.org\/10.1186\/1471-2407-9-152","journal-title":"BMC Cancer"},{"key":"9875_CR65","doi-asserted-by":"publisher","first-page":"7986","DOI":"10.1158\/1078-0432.ccr-05-1354","volume":"11","author":"C Cutcliffe","year":"2005","unstructured":"Cutcliffe C, Kersey D, Huang CC, Zeng Y, Walterhouse D, Perlman EJ (2005) Clear cell sarcoma of the kidney: up-regulation of neural markers with activation of the sonic hedgehog and Akt pathways. Clin Cancer Res 11:7986\u20137994. https:\/\/doi.org\/10.1158\/1078-0432.ccr-05-1354","journal-title":"Clin Cancer Res"},{"key":"9875_CR66","doi-asserted-by":"publisher","first-page":"4740","DOI":"10.1158\/1078-0432.ccr-07-0143","volume":"13","author":"ML Gumz","year":"2007","unstructured":"Gumz ML, Zou H, Kreinest PA, Childs AC, Belmonte LS, LeGrand SN, Wu KJ, Luxon BA, Sinha M, Parker AS, Sun LZ, Ahlquist DA, Wood CG, Copland JA (2007) Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma. Clin Cancer Res 13:4740\u20134749. https:\/\/doi.org\/10.1158\/1078-0432.ccr-07-0143","journal-title":"Clin Cancer Res"},{"key":"9875_CR67","doi-asserted-by":"publisher","first-page":"4674","DOI":"10.1158\/0008-5472.can-09-0146","volume":"69","author":"R Beroukhim","year":"2009","unstructured":"Beroukhim R, Brunet JP, Di Napoli A, Mertz KD, Seeley A, Pires MM, Linhart D, Worrell RA, Moch H, Rubin MA, Sellers WR, Meyerson M, Linehan WM, Kaelin WG Jr, Signoretti S (2009) Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney. Cancer Res 69:4674\u20134681. https:\/\/doi.org\/10.1158\/0008-5472.can-09-0146","journal-title":"Cancer Res"},{"key":"9875_CR68","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13072-015-0014-8","volume":"8","author":"A D\u00edez-Villanueva","year":"2015","unstructured":"D\u00edez-Villanueva A, Mallona I, Peinado MA (2015) Wanderer, an interactive viewer to explore DNA methylation and gene expression data in human cancer. Epigenetics Chromatin 8:22. https:\/\/doi.org\/10.1186\/s13072-015-0014-8","journal-title":"Epigenetics Chromatin"},{"key":"9875_CR69","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/ncpuro0456","volume":"3","author":"MR Ruggieri Sr","year":"2006","unstructured":"Ruggieri MR Sr (2006) Mechanisms of disease: role of purinergic signaling in the pathophysiology of bladder dysfunction. Nat Clin Pract Urol 3:206\u2013215. https:\/\/doi.org\/10.1038\/ncpuro0456","journal-title":"Nat Clin Pract Urol"},{"key":"9875_CR70","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1002\/nau.23099","volume":"36","author":"K Takezawa","year":"2017","unstructured":"Takezawa K, Kondo M, Nonomura N, Shimada S (2017) Urothelial ATP signaling: what is its role in bladder sensation? Neurourol Urodyn 36:966\u2013972. https:\/\/doi.org\/10.1002\/nau.23099","journal-title":"Neurourol Urodyn"},{"key":"9875_CR71","doi-asserted-by":"publisher","first-page":"F1084","DOI":"10.1152\/ajprenal.00118.2004","volume":"287","author":"LA Birder","year":"2004","unstructured":"Birder LA, Ruan HZ, Chopra B, Xiang Z, Barrick S, Buffington CA, Roppolo JR, Ford AP, de Groat WC, Burnstock G (2004) Alterations in P2X and P2Y purinergic receptor expression in urinary bladder from normal cats and cats with interstitial cystitis. Am J Physiol Renal Physiol 287:F1084\u2013F1091. https:\/\/doi.org\/10.1152\/ajprenal.00118.2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"9875_CR72","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.juro.2015.05.080","volume":"194","author":"I Silva","year":"2015","unstructured":"Silva I, Ferreirinha F, Magalh\u00e3es-Cardoso MT, Silva-Ramos M, Correia-de-S\u00e1 P (2015) Activation of P2Y6 receptors facilitates nonneuronal adenosine triphosphate and acetylcholine release from urothelium with the lamina propria of men with bladder outlet obstruction. J Urol 194:1146\u20131154. https:\/\/doi.org\/10.1016\/j.juro.2015.05.080","journal-title":"J Urol"},{"key":"9875_CR73","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1111\/j.1464-410X.2004.04858.x","volume":"93","author":"HV Tempest","year":"2004","unstructured":"Tempest HV, Dixon AK, Turner WH, Elneil S, Sellers LA, Ferguson DR (2004) P2X and P2X receptor expression in human bladder urothelium and changes in interstitial cystitis. BJU Int 93:1344\u20131348. https:\/\/doi.org\/10.1111\/j.1464-410X.2004.04858.x","journal-title":"BJU Int"},{"key":"9875_CR74","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/nau.23138","volume":"36","author":"H-T Liu","year":"2017","unstructured":"Liu H-T, Kuo H-C (2017) Expressions of urothelial functional proteins in idiopathic detrusor overactivity patients refractory to antimuscarinic therapy with different urodynamic characteristics. Neurourol Urodyn 36:1313\u20131319. https:\/\/doi.org\/10.1002\/nau.23138","journal-title":"Neurourol Urodyn"},{"key":"9875_CR75","doi-asserted-by":"publisher","first-page":"F396","DOI":"10.1152\/ajprenal.00127.2013","volume":"305","author":"S Shabir","year":"2013","unstructured":"Shabir S, Cross W, Kirkwood LA, Pearson JF, Appleby PA, Walker D, Eardley I, Southgate J (2013) Functional expression of purinergic P2 receptors and transient receptor potential channels by the human urothelium. Am J Physiol Renal Physiol 305:F396-406. https:\/\/doi.org\/10.1152\/ajprenal.00127.2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"9875_CR76","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/s41598-017-00824-2","volume":"7","author":"S Kira","year":"2017","unstructured":"Kira S, Yoshiyama M, Tsuchiya S, Shigetomi E, Miyamoto T, Nakagomi H, Shibata K, Mochizuki T, Takeda M, Koizumi S (2017) P2Y6-deficiency increases micturition frequency and attenuates sustained contractility of the urinary bladder in mice. Sci Rep 7:771. https:\/\/doi.org\/10.1038\/s41598-017-00824-2","journal-title":"Sci Rep"},{"key":"9875_CR77","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jss.2012.11.041","volume":"183","author":"M Liu","year":"2013","unstructured":"Liu M, Xu Y-F, Feng Y, Yang F-Q, Luo J, Zhai W, Che J-P, Wang G-C, Zheng J-H (2013) Epigallocatechin gallate attenuates interstitial cystitis in human bladder urothelium cells by modulating purinergic receptors. J Surg Res 183:397\u2013404. https:\/\/doi.org\/10.1016\/j.jss.2012.11.041","journal-title":"J Surg Res"},{"key":"9875_CR78","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1093\/glycob\/cwq211","volume":"21","author":"F Vacca","year":"2011","unstructured":"Vacca F, D\u2019Ambrosi N, Nestola V, Amadio S, Giustizieri M, Cucchiaroni ML, Tozzi A, Velluz MC, Mercuri NB, Volonte C (2011) N-Glycans mutations rule oligomeric assembly and functional expression of P2X3 receptor for extracellular ATP. Glycobiology 21:634\u2013643. https:\/\/doi.org\/10.1093\/glycob\/cwq211","journal-title":"Glycobiology"},{"key":"9875_CR79","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.pop.2019.02.004","volume":"46","author":"GM Irwin","year":"2019","unstructured":"Irwin GM (2019) Urinary incontinence. Prim Care: Clin Off Practice 46:233\u2013242. https:\/\/doi.org\/10.1016\/j.pop.2019.02.004","journal-title":"Prim Care: Clin Off Practice"},{"key":"9875_CR80","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1111\/bph.12711","volume":"171","author":"I Carneiro","year":"2014","unstructured":"Carneiro I, Timoteo MA, Silva I, Vieira C, Baldaia C, Ferreirinha F, Silva-Ramos M, Correia-de-Sa P (2014) Activation of P2Y6 receptors increases the voiding frequency in anaesthetized rats by releasing ATP from the bladder urothelium. Br J Pharmacol 171:3404\u20133419. https:\/\/doi.org\/10.1111\/bph.12711","journal-title":"Br J Pharmacol"},{"key":"9875_CR81","doi-asserted-by":"publisher","first-page":"RC166","DOI":"10.1523\/JNEUROSCI.21-18-j0002.2001","volume":"21","author":"KH Moore","year":"2001","unstructured":"Moore KH, Ray FR, Barden JA (2001) Loss of purinergic P2X3 and P2X5 receptor innervation in human detrusor from adults with urge incontinence. J Neurosci 21:RC166\u2013RC166. https:\/\/doi.org\/10.1523\/JNEUROSCI.21-18-j0002.2001","journal-title":"J Neurosci"},{"key":"9875_CR82","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00192-009-0976-9","volume":"21","author":"BT Haylen","year":"2010","unstructured":"Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, Monga A, Petri E, Rizk DE, Sand PK, Schaer GN (2010) An International Urogynecological Association (IUGA)\/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J 21:5\u201326. https:\/\/doi.org\/10.1007\/s00192-009-0976-9","journal-title":"Int Urogynecol J"},{"key":"9875_CR83","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1002\/nau.24322","volume":"39","author":"S Firouzmand","year":"2020","unstructured":"Firouzmand S, Ajori L, Towse J, Allameh F, Najafi S, Javed S, John B, Langley SEM, Fry CH, Young JS (2020) Investigating the associations of mucosal P2Y6 receptor expression and urinary ATP and ADP concentrations, with symptoms of overactive bladder. Neurourol Urodyn 39:926\u2013934. https:\/\/doi.org\/10.1002\/nau.24322","journal-title":"Neurourol Urodyn"},{"key":"9875_CR84","doi-asserted-by":"publisher","unstructured":"Hao Y, Wang L, Chen H, Hill WG, Robson SC, Zeidel ML, Yu W (2019) Targetable purinergic receptors P2Y12 and A2b antagonistically regulate bladder function. JCI Insight 4(16):e122112. https:\/\/doi.org\/10.1172\/jci.insight.122112","DOI":"10.1172\/jci.insight.122112"},{"key":"9875_CR85","doi-asserted-by":"publisher","first-page":"805236","DOI":"10.1155\/2014\/805236","volume":"2014","author":"I Sterle","year":"2014","unstructured":"Sterle I, Zupancic D, Romih R (2014) Correlation between urothelial differentiation and sensory proteins P2X3, P2X5, TRPV1, and TRPV4 in normal urothelium and papillary carcinoma of human bladder. Biomed Res Int 2014:805236. https:\/\/doi.org\/10.1155\/2014\/805236","journal-title":"Biomed Res Int"},{"key":"9875_CR86","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.7150\/ijbs.27151","volume":"14","author":"M Ding","year":"2018","unstructured":"Ding M, Zhan H, Liao X, Li A, Zhong Y, Gao Q, Liu Y, Huang W, Cai Z (2018) Enhancer RNA - P2RY2e induced by estrogen promotes malignant behaviors of bladder cancer. Int J Biol Sci 14:1268\u20131276. https:\/\/doi.org\/10.7150\/ijbs.27151","journal-title":"Int J Biol Sci"},{"key":"9875_CR87","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/ca.22655","volume":"29","author":"V Puppo","year":"2016","unstructured":"Puppo V, Puppo G (2016) Comprehensive review of the anatomy and physiology of male ejaculation: premature ejaculation is not a disease. Clin Anat 29:111\u2013119. https:\/\/doi.org\/10.1002\/ca.22655","journal-title":"Clin Anat"},{"key":"9875_CR88","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/j.1440-1681.2005.04268.x","volume":"32","author":"JM Haynes","year":"2005","unstructured":"Haynes JM, Ventura S (2005) Current models of human prostate contractility. Clin Exp Pharmacol Physiol 32:797\u2013804. https:\/\/doi.org\/10.1111\/j.1440-1681.2005.04268.x","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"9875_CR89","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/nau.22519","volume":"34","author":"CW White","year":"2015","unstructured":"White CW, Short JL, Evans RJ, Ventura S (2015) Development of a P2X1-purinoceptor mediated contractile response in the aged mouse prostate gland through slowing down of ATP breakdown. Neurourol Urodyn 34:292\u2013298. https:\/\/doi.org\/10.1002\/nau.22519","journal-title":"Neurourol Urodyn"},{"key":"9875_CR90","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1177\/1756287212447839","volume":"4","author":"D Rodr\u00edguez","year":"2012","unstructured":"Rodr\u00edguez D, Olumi AF (2012) Management of spermatic cord tumors: a rare urologic malignancy. Ther Adv Urol 4:325\u2013334. https:\/\/doi.org\/10.1177\/1756287212447839","journal-title":"Ther Adv Urol"},{"key":"9875_CR91","doi-asserted-by":"publisher","first-page":"137","DOI":"10.4103\/0970-1591.78417","volume":"27","author":"R Ramamurthy","year":"2011","unstructured":"Ramamurthy R, Periasamy S, Mettupalayam V (2011) Primary malignancy of seminal vesicle: a rare entity. Indian J Urol 27:137\u2013139. https:\/\/doi.org\/10.4103\/0970-1591.78417","journal-title":"Indian J Urol"},{"key":"9875_CR92","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/aja.2012.20","volume":"14","author":"C-H Yeung","year":"2012","unstructured":"Yeung C-H, Wang K, Cooper TG (2012) Why are epididymal tumours so rare? Asian J Androl 14:465\u2013475. https:\/\/doi.org\/10.1038\/aja.2012.20","journal-title":"Asian J Androl"},{"key":"9875_CR93","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1016\/s0022-5347(05)00892-x","volume":"175","author":"S Sutcliffe","year":"2006","unstructured":"Sutcliffe S, Zenilman JM, Ghanem KG, Jadack RA, Sokoll LJ, Elliott DJ, Nelson WG, De Marzo AM, Cole SR, Isaacs WB, Platz EA (2006) Sexually transmitted infections and prostatic inflammation\/cell damage as measured by serum prostate specific antigen concentration. J Urol 175:1937\u20131942. https:\/\/doi.org\/10.1016\/s0022-5347(05)00892-x","journal-title":"J Urol"},{"key":"9875_CR94","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.juro.2017.08.001","volume":"199","author":"E Shrestha","year":"2018","unstructured":"Shrestha E, White JR, Yu SH, Kulac I, Ertunc O, De Marzo AM, Yegnasubramanian S, Mangold LA, Partin AW, Sfanos KS (2018) Profiling the urinary microbiome in men with positive versus negative biopsies for prostate cancer. J Urol 199:161\u2013171. https:\/\/doi.org\/10.1016\/j.juro.2017.08.001","journal-title":"J Urol"},{"key":"9875_CR95","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1023\/a:1004110529753","volume":"32","author":"M Slater","year":"2000","unstructured":"Slater M, Barden JA, Murphy CR (2000) The purinergic calcium channels P2X1,2,5,7 are down-regulated while P2X3,4,6 are up-regulated during apoptosis in the ageing rat prostate. Histochem J 32:571\u2013580. https:\/\/doi.org\/10.1023\/a:1004110529753","journal-title":"Histochem J"},{"key":"9875_CR96","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ijantimicag.2007.08.028","volume":"31","author":"JN Krieger","year":"2008","unstructured":"Krieger JN, Lee SWH, Jeon J, Cheah PY, Liong ML, Riley DE (2008) Epidemiology of prostatitis. Int J Antimicrob Agents 31:85\u201390. https:\/\/doi.org\/10.1016\/j.ijantimicag.2007.08.028","journal-title":"Int J Antimicrob Agents"},{"key":"9875_CR97","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/35039519","volume":"407","author":"DA Cockayne","year":"2000","unstructured":"Cockayne DA, Hamilton SG, Zhu QM, Dunn PM, Zhong Y, Novakovic S, Malmberg AB, Cain G, Berson A, Kassotakis L, Hedley L, Lachnit WG, Burnstock G, McMahon SB, Ford AP (2000) Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice. Nature 407:1011\u20131015. https:\/\/doi.org\/10.1038\/35039519","journal-title":"Nature"},{"key":"9875_CR98","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1002\/nau.21060","volume":"30","author":"H Zhang","year":"2011","unstructured":"Zhang H, Liu L, Lu G, Chen Z, Fang Q, Yang Z, Li L, Li W, Song B, Zhou Z (2011) Chemical irritation of the prostate sensitizes P(2)X(3) receptor-mediated responses in rat dorsal root ganglion neurons. Neurourol Urodyn 30:612\u2013618. https:\/\/doi.org\/10.1002\/nau.21060","journal-title":"Neurourol Urodyn"},{"key":"9875_CR99","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1097\/j.pain.0000000000000201","volume":"156","author":"ES Schwartz","year":"2015","unstructured":"Schwartz ES, Xie A, La JH, Gebhart GF (2015) Nociceptive and inflammatory mediator upregulation in a mouse model of chronic prostatitis. Pain 156:1537\u20131544. https:\/\/doi.org\/10.1097\/j.pain.0000000000000201","journal-title":"Pain"},{"key":"9875_CR100","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1590\/S1677-5538.IBJU.2013.02.17","volume":"39","author":"H Zhang","year":"2013","unstructured":"Zhang H, Liu L, Yang Z, Pan J, Chen Z, Fang Q, Li W, Li L, Lu G, Zhou Z (2013) P2X7 receptor mediates activation of microglial cells in prostate of chemically irritated rats. Int Braz J Urol 39:276\u2013285. https:\/\/doi.org\/10.1590\/S1677-5538.IBJU.2013.02.17","journal-title":"Int Braz J Urol"},{"key":"9875_CR101","doi-asserted-by":"publisher","unstructured":"Cheng Y, Mansfield KJ, Allen W, Chess-Williams R, Burcher E, Moore KH\u00a0(2014) ATP during early bladder stretch is important for urgency in detrusor overactivity patients. Biomed Res Int 2014:204604. https:\/\/doi.org\/10.1155\/2014\/204604","DOI":"10.1155\/2014\/204604"},{"key":"9875_CR102","doi-asserted-by":"publisher","unstructured":"Abbasian B, Shair A, O'Gorman DB, Pena-Diaz AM, Brennan L, Engelbrecht K, Koenig DW, Reid G, Burton JP\u00a0(2019) Potential role of extracellular ATP released by bacteria in bladder infection and contractility. mSphere 4:e00439\u2013e00419. https:\/\/doi.org\/10.1128\/mSphere.00439-19","DOI":"10.1128\/mSphere.00439-19"},{"key":"9875_CR103","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1523\/jneurosci.4930-11.2012","volume":"32","author":"JP de Rivero Vaccari","year":"2012","unstructured":"de Rivero Vaccari JP, Bastien D, Yurcisin G, Pineau I, Dietrich WD, De Koninck Y, Keane RW, Lacroix S (2012) P2X4 receptors influence inflammasome activation after spinal cord injury. J Neurosci: Off J Soc Neurosci 32:3058\u20133066. https:\/\/doi.org\/10.1523\/jneurosci.4930-11.2012","journal-title":"J Neurosci: Off J Soc Neurosci"},{"key":"9875_CR104","doi-asserted-by":"publisher","unstructured":"Cs\u00f3ka B, N\u00e9meth ZH, Szab\u00f3 I, Davies DL, Varga ZV, P\u00e1l\u00f3czi J, Falzoni S, Di Virgilio F, Muramatsu R, Yamashita T, Pacher P, Hask\u00f3 G (2018) Macrophage P2X4 receptors augment bacterial killing and protect against sepsis. JCI Insight 3.\u00a0https:\/\/doi.org\/10.1172\/jci.insight.99431","DOI":"10.1172\/jci.insight.99431"},{"key":"9875_CR105","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.bcp.2011.05.013","volume":"82","author":"Q Wei","year":"2011","unstructured":"Wei Q, Costanzi S, Liu QZ, Gao ZG, Jacobson KA (2011) Activation of the P2Y1 receptor induces apoptosis and inhibits proliferation of prostate cancer cells. Biochem Pharmacol 82:418\u2013425. https:\/\/doi.org\/10.1016\/j.bcp.2011.05.013","journal-title":"Biochem Pharmacol"},{"key":"9875_CR106","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1038\/bjc.2013.484","volume":"109","author":"WH Li","year":"2013","unstructured":"Li WH, Qiu Y, Zhang HQ, Liu Y, You JF, Tian XX, Fang WG (2013) P2Y2 receptor promotes cell invasion and metastasis in prostate cancer cells. Br J Cancer 109:1666\u20131675. https:\/\/doi.org\/10.1038\/bjc.2013.484","journal-title":"Br J Cancer"},{"key":"9875_CR107","doi-asserted-by":"publisher","first-page":"529","DOI":"10.21873\/anticanres.11345","volume":"37","author":"K Lertsuwan","year":"2017","unstructured":"Lertsuwan K et al (2017) Purinergic receptor expression and cellular responses to purinergic agonists in human prostate cancer cells. Anticancer Res 37:529\u2013537. https:\/\/doi.org\/10.21873\/anticanres.11345","journal-title":"Anticancer Res"},{"key":"9875_CR108","doi-asserted-by":"publisher","unstructured":"Maynard JP, Lu J, Vidal I, Hicks J, Mummert L, Ali T, Kempski R, Carter AM, Sosa RY, Peiffer LB, Joshu CE, Lotan TL, De Marzo AM, Sfanos KS (2022) P2X4 purinergic receptors offer a therapeutic target for aggressive prostate cancer. J Pathol\u00a0256(2):149\u201363\u00a0https:\/\/doi.org\/10.1002\/path.5815","DOI":"10.1002\/path.5815"},{"key":"9875_CR109","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/j.1464-410X.2007.07293.x","volume":"101","author":"M Shabbir","year":"2008","unstructured":"Shabbir M, Ryten M, Thompson C, Mikhailidis D, Burnstock G (2008) Characterization of calcium-independent purinergic receptor-mediated apoptosis in hormone-refractory prostate cancer. BJU Int 101:352\u2013359. https:\/\/doi.org\/10.1111\/j.1464-410X.2007.07293.x","journal-title":"BJU Int"},{"key":"9875_CR110","doi-asserted-by":"publisher","first-page":"5686","DOI":"10.1074\/jbc.M510452200","volume":"281","author":"R Nandigama","year":"2006","unstructured":"Nandigama R, Padmasekar M, Wartenberg M, Sauer H (2006) Feed forward cycle of hypotonic stress-induced ATP release, purinergic receptor activation, and growth stimulation of prostate cancer cells. J Biol Chem 281:5686\u20135693. https:\/\/doi.org\/10.1074\/jbc.M510452200","journal-title":"J Biol Chem"},{"key":"9875_CR111","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.canlet.2004.05.023","volume":"215","author":"L Chen","year":"2004","unstructured":"Chen L, He H-y, Li H-m, Zheng J, Heng W-j, You J-f, Fang W-g (2004) ERK1\/2 and p38 pathways are required for P2Y receptor-mediated prostate cancer invasion. Cancer Lett 215:239\u2013247. https:\/\/doi.org\/10.1016\/j.canlet.2004.05.023","journal-title":"Cancer Lett"},{"key":"9875_CR112","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.canlet.2010.01.010","volume":"293","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Gong L-h, Zhang H-q, Du Q, You J-f, Tian X-x, Fang W-g (2010) Extracellular ATP enhances in vitro invasion of prostate cancer cells by activating Rho GTPase and upregulating MMPs expression. Cancer Lett 293:189\u2013197. https:\/\/doi.org\/10.1016\/j.canlet.2010.01.010","journal-title":"Cancer Lett"},{"key":"9875_CR113","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s10735-004-6166-7","volume":"36","author":"M Slater","year":"2005","unstructured":"Slater M, Danieletto S, Barden JA (2005) Expression of the apoptotic calcium channel P2X7 in the glandular epithelium. J Mol Histol 36:159\u2013165. https:\/\/doi.org\/10.1007\/s10735-004-6166-7","journal-title":"J Mol Histol"},{"key":"9875_CR114","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41388-018-0426-6","volume":"38","author":"SM Gilbert","year":"2019","unstructured":"Gilbert SM, Oliphant CJ, Hassan S, Peille AL, Bronsert P, Falzoni S, Di Virgilio F, McNulty S, Lara R (2019) ATP in the tumour microenvironment drives expression of nfP2X7, a key mediator of cancer cell survival. Oncogene 38:194\u2013208. https:\/\/doi.org\/10.1038\/s41388-018-0426-6","journal-title":"Oncogene"},{"key":"9875_CR115","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1093\/carcin\/bgu019","volume":"35","author":"A Ghalali","year":"2014","unstructured":"Ghalali A, Wiklund F, Zheng H, Stenius U, H\u00f6gberg J (2014) Atorvastatin prevents ATP-driven invasiveness via P2X7 and EHBP1 signaling in PTEN-expressing prostate cancer cells. Carcinogenesis 35:1547\u20131555. https:\/\/doi.org\/10.1093\/carcin\/bgu019","journal-title":"Carcinogenesis"},{"key":"9875_CR116","doi-asserted-by":"publisher","unstructured":"Solini A, Simeon V, Derosa L, Orlandi P, Rossi C, Fontana A, Galli L, Di Desidero T, Fioravanti A, Lucchesi S, Coltelli L, Ginocchi L, Allegrini G, Danesi R, Falcone A, Bocci G (2015) Genetic interaction of P2X7 receptor and VEGFR-2 polymorphisms identifies a favorable prognostic profile in prostate cancer patients. Oncotarget 6:28743\u201328754. https:\/\/doi.org\/10.18632\/oncotarget.4926","DOI":"10.18632\/oncotarget.4926"},{"key":"9875_CR117","doi-asserted-by":"publisher","unstructured":"He J, Zhou Y, Arredondo Carrera HM, Sprules A, Neagu R, Zarkesh SA, Eaton C, Luo J, Gartland A, Wang N (2020) Inhibiting the P2X4 receptor suppresses prostate cancer growth in vitro and in vivo, suggesting a potential clinical target. Cells 9(11). https:\/\/doi.org\/10.3390\/cells9112511","DOI":"10.3390\/cells9112511"},{"key":"9875_CR118","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/ju.0000000000000533","volume":"203","author":"NM Haney","year":"2020","unstructured":"Haney NM, Faisal FA, Lu J, Guedes LB, Reuter VE, Scher HI, Eastham JA, Marchionni L, Joshu C, Gopalan A, Lotan TL (2020) PTEN loss with ERG negative status is associated with lethal disease after radical prostatectomy. J Urol 203:344\u2013350. https:\/\/doi.org\/10.1097\/ju.0000000000000533","journal-title":"J Urol"},{"key":"9875_CR119","doi-asserted-by":"publisher","first-page":"110112","DOI":"10.1016\/j.biopha.2020.110112","volume":"127","author":"A Ghalali","year":"2020","unstructured":"Ghalali A, Ye Z-W, H\u00f6gberg J, Stenius U (2020) PTEN and PHLPP crosstalk in cancer cells and in TGF\u03b2-activated stem cells. Biomed Pharmacother 127:110112. https:\/\/doi.org\/10.1016\/j.biopha.2020.110112","journal-title":"Biomed Pharmacother"},{"key":"9875_CR120","doi-asserted-by":"publisher","unstructured":"Ahearn TU, Pettersson A, Ebot EM, Gerke T, Graff RE, Morais CL, Hicks JL, Wilson KM, Rider JR, Sesso HD, Fiorentino M, Flavin R, Finn S, Giovannucci EL, Loda M, Stampfer MJ, De Marzo AM, Mucci LA, Lotan TL (2016) A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer. J Natl Cancer Inst 108(2). https:\/\/doi.org\/10.1093\/jnci\/djv346","DOI":"10.1093\/jnci\/djv346"},{"key":"9875_CR121","doi-asserted-by":"publisher","unstructured":"Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, Varambally S, Cao X, Tchinda J, Kuefer R, Lee C, Montie JE, Shah RB, Pienta KJ, Rubin MA, Chinnaiyan AM (2005) Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science (New York, N.Y.) 310:644\u2013648. https:\/\/doi.org\/10.1126\/science.1117679","DOI":"10.1126\/science.1117679"},{"key":"9875_CR122","doi-asserted-by":"publisher","unstructured":"Tian TV, Tomavo N, Huot L, Flourens A, Bonnelye E, Flajollet S, Hot D, Leroy X, de Launoit Y, Duterque-Coquillaud M (2014) Identification of novel TMPRSS2:ERG mechanisms in prostate cancer metastasis: involvement of MMP9 and PLXNA2. Oncogene 33:2204\u20132214. https:\/\/doi.org\/10.1038\/onc.2013.176","DOI":"10.1038\/onc.2013.176"},{"key":"9875_CR123","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1053\/hp.2000.6698","volume":"31","author":"L Bubendorf","year":"2000","unstructured":"Bubendorf L, Sch\u00f6pfer A, Wagner U, Sauter G, Moch H, Willi N, Gasser TC, Mihatsch MJ (2000) Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol 31:578\u2013583. https:\/\/doi.org\/10.1053\/hp.2000.6698","journal-title":"Hum Pathol"},{"key":"9875_CR124","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1155\/2012\/758181","volume":"758181\u2013758181","author":"S Falk","year":"2012","unstructured":"Falk S, Uldall M, Heegaard A-M (2012) The role of purinergic receptors in cancer-induced bone pain. J Osteoporos 758181\u2013758181:2012. https:\/\/doi.org\/10.1155\/2012\/758181","journal-title":"J Osteoporos"},{"key":"9875_CR125","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.neulet.2019.02.024","volume":"701","author":"Y Yan","year":"2019","unstructured":"Yan Y, Liang Y, Ding T, Chu H (2019) PI3K\/Akt signaling pathway may be involved in MCP-1-induced P2X4R expression in cultured microglia and cancer-induced bone pain rats. Neurosci Lett 701:100\u2013105. https:\/\/doi.org\/10.1016\/j.neulet.2019.02.024","journal-title":"Neurosci Lett"},{"key":"9875_CR126","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1002\/jnr.23443","volume":"92","author":"X-H Jin","year":"2014","unstructured":"Jin X-H, Wang L-N, Zuo J-L, Yang J-P, Liu S-L (2014) P2X4 receptor in the dorsal horn partially contributes to brain-derived neurotrophic factor oversecretion and toll-like receptor-4 receptor activation associated with bone cancer pain. J Neurosci Res 92:1690\u20131702. https:\/\/doi.org\/10.1002\/jnr.23443","journal-title":"J Neurosci Res"},{"key":"9875_CR127","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1111\/j.1464-410X.2007.07385.x","volume":"101","author":"RC Calvert","year":"2008","unstructured":"Calvert RC, Khan MA, Thompson CS, Mikhailidis DP, Burnstock G (2008) A functional study of purinergic signalling in the normal and pathological rabbit corpus cavernosum. BJU Int 101:1043\u20131047. https:\/\/doi.org\/10.1111\/j.1464-410X.2007.07385.x","journal-title":"BJU Int"},{"key":"9875_CR128","doi-asserted-by":"publisher","first-page":"314","DOI":"10.5489\/cuaj.1127","volume":"3","author":"S Gur","year":"2009","unstructured":"Gur S, Hellstrom WJ (2009) Activation of P2Y1 and P2Y2 nucleotide receptors by adenosine 5\u2019-triphosphate analogues augmented nerve-mediated relaxation of human corpus cavernosum. Can Urol Assoc J = J l\u2019Assoc Urol Can 3:314\u2013318. https:\/\/doi.org\/10.5489\/cuaj.1127","journal-title":"Can Urol Assoc J = J l'Assoc Urol Can"},{"key":"9875_CR129","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1365-2605.2007.00828.x","volume":"32","author":"DH Lau","year":"2009","unstructured":"Lau DH, Metcalfe MJ, Mumtaz FH, Mikhailidis DP, Thompson CS (2009) Purinergic modulation of human corpus cavernosum relaxation. Int J Androl 32:149\u2013155. https:\/\/doi.org\/10.1111\/j.1365-2605.2007.00828.x","journal-title":"Int J Androl"},{"key":"9875_CR130","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/j.jsxm.2017.09.013","volume":"14","author":"MR Odom","year":"2017","unstructured":"Odom MR, Pak ES, Brown DA, Hannan JL (2017) Enhanced electrical field stimulated nitrergic and purinergic vasoreactivity in distal vs proximal internal pudendal arteries. J Sex Med 14:1285\u20131296. https:\/\/doi.org\/10.1016\/j.jsxm.2017.09.013","journal-title":"J Sex Med"},{"key":"9875_CR131","doi-asserted-by":"publisher","unstructured":"Gur S, Kadowitz PJ, Abdel-Mageed AB, Kendirci M, Sikka SC, Burnstock G, Hellstrom WJG  (2009) Management of erectile function by penile purinergic p2 receptors in the diabetic rat. J Urol 181:2375\u20132382. https:\/\/doi.org\/10.1016\/j.juro.2009.01.002","DOI":"10.1016\/j.juro.2009.01.002"},{"key":"9875_CR132","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/aja.2009.70","volume":"12","author":"S Gur","year":"2010","unstructured":"Gur S, Sikka SC, Knight GE, Burnstock G, Hellstrom WJG (2010) Purinergic contraction of the rat vas deferens in L-NAME-induced hypertension: effect of sildenafil. Asian J Androl 12:415\u2013421. https:\/\/doi.org\/10.1038\/aja.2009.70","journal-title":"Asian J Androl"},{"key":"9875_CR133","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S0022-5347(01)61828-7","volume":"161","author":"M Shalev","year":"1999","unstructured":"Shalev M, Staerman F, Allain H, Lobel B, Saiag B (1999) Stimulation of P2y purinoceptors induces, via nitric oxide production, endothelium-dependent relaxation of human isolated corpus cavernosum. J Urol 161:955\u2013959","journal-title":"J Urol"},{"key":"9875_CR134","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1046\/j.1464-410x.2002.02979.x","volume":"90","author":"H Kilicarslan","year":"2002","unstructured":"Kilicarslan H, Yildirim S, Bagcivan I, Ayan S, Sarac B, Sarioglu Y (2002) Effect of chronic renal failure on the purinergic responses of corpus cavernosal smooth muscle in rabbits. BJU Int 90:596\u2013600. https:\/\/doi.org\/10.1046\/j.1464-410x.2002.02979.x","journal-title":"BJU Int"},{"key":"9875_CR135","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s11255-008-9332-0","volume":"40","author":"MK Yildirim","year":"2008","unstructured":"Yildirim MK, Bagcivan I, Sarac B, Kilicarslan H, Yildirim S, Kaya T (2008) Effect of hypothyroidism on the purinergic responses of corpus cavernosal smooth muscle in rabbits. Int Urol Nephrol 40:691\u2013699. https:\/\/doi.org\/10.1007\/s11255-008-9332-0","journal-title":"Int Urol Nephrol"},{"key":"9875_CR136","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1080\/15257770802145744","volume":"27","author":"M Faria","year":"2008","unstructured":"Faria M, Magalhaes-Cardoso T, Lafuente-de-Carvalho JM, Correia-de Sa P (2008) Decreased ecto-NTPDase1\/CD39 activity leads to desensitization of P2 purinoceptors regulating tonus of corpora cavernosa in impotent men with endothelial dysfunction. Nucleosides, Nucleotides and Nucleic Acids 27:761\u2013768. https:\/\/doi.org\/10.1080\/15257770802145744","journal-title":"Nucleosides, Nucleotides and Nucleic Acids"},{"issue":"229","key":"9875_CR137","doi-asserted-by":"publisher","first-page":"e221","DOI":"10.1016\/j.urology.2018.03.018","volume":"116","author":"P Liu","year":"2018","unstructured":"Liu P, Jiang J, Xia J, Jiang R (2018) Effect of low androgen status on the expression of P2Y receptors in the corpus cavernosum of rats. Urology 116(229):e221-229.e226. https:\/\/doi.org\/10.1016\/j.urology.2018.03.018","journal-title":"Urology"},{"key":"9875_CR138","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/and.12217","volume":"47","author":"CL Li","year":"2015","unstructured":"Li CL, Yang XL, Wang JJ, Du GH, Yang WM, Zhang HP (2015) Effects of intracavernous injection of P2X3 and NK1 receptor antagonists on erectile dysfunction induced by spinal cord transection in rats. Andrologia 47:25\u201329. https:\/\/doi.org\/10.1111\/and.12217","journal-title":"Andrologia"},{"key":"9875_CR139","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/47495","volume":"403","author":"K Mulryan","year":"2000","unstructured":"Mulryan K, Gitterman DP, Lewis CJ, Vial C, Leckie BJ, Cobb AL, Brown JE, Conley EC, Buell G, Pritchard CA, Evans RJ (2000) Reduced vas deferens contraction and male infertility in mice lacking P2X1 receptors. Nature 403:86\u201389. https:\/\/doi.org\/10.1038\/47495","journal-title":"Nature"},{"key":"9875_CR140","doi-asserted-by":"publisher","first-page":"20825","DOI":"10.1073\/pnas.1318624110","volume":"110","author":"CW White","year":"2013","unstructured":"White CW, Choong YT, Short JL, Exintaris B, Malone DT, Allen AM, Evans RJ, Ventura S (2013) Male contraception via simultaneous knockout of alpha1A-adrenoceptors and P2X1-purinoceptors in mice. Proc Natl Acad Sci USA 110:20825\u201320830. https:\/\/doi.org\/10.1073\/pnas.1318624110","journal-title":"Proc Natl Acad Sci USA"},{"key":"9875_CR141","doi-asserted-by":"publisher","unstructured":"Walenta L, Fleck D, Frohlich T, von Eysmondt H, Arnold GJ, Spehr J, Schwarzer JU, Kohn FM, Spehr M, Mayerhofer A (2018) ATP-mediated events in peritubular cells contribute to sterile testicular inflammation. Sci Rep 8:1431. https:\/\/doi.org\/10.1038\/s41598-018-19624-3","DOI":"10.1038\/s41598-018-19624-3"},{"key":"9875_CR142","doi-asserted-by":"publisher","unstructured":"Fleck D, Kenzler L, Mundt N, Strauch M, Uesaka N, Moosmann R, Bruentgens F, Missel A, Mayerhofer A, Merhof D, Spehr J, Spehr M\u00a0(2021) ATP activation of peritubular cells drives testicular sperm transport. Elife 10:e62885. https:\/\/doi.org\/10.7554\/eLife.62885","DOI":"10.7554\/eLife.62885"},{"key":"9875_CR143","doi-asserted-by":"publisher","unstructured":"Giuliani AL, Sarti AC and Di Virgilio F (2021) Ectonucleotidases in acute and chronic inflammation. Front Pharmacol 11:619458. https:\/\/doi.org\/10.3389\/fphar.2020.619458","DOI":"10.3389\/fphar.2020.619458"},{"key":"9875_CR144","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.molmed.2010.12.006","volume":"17","author":"MJ Zylka","year":"2011","unstructured":"Zylka MJ (2011) Pain-relieving prospects for adenosine receptors and ectonucleotidases. Trends Mol Med 17:188\u2013196. https:\/\/doi.org\/10.1016\/j.molmed.2010.12.006","journal-title":"Trends Mol Med"},{"key":"9875_CR145","first-page":"1983","volume":"206","author":"CB Haas","year":"2021","unstructured":"Haas CB, Lov\u00e1szi M, Braganhol E, Pacher P, Hask\u00f3 G (2021) (2021) Ectonucleotidases in inflammation immunity and cancer. J Immunol Baltimore (Baltimore, Md.\u202f: 1950) 206:1983\u20131990","journal-title":"J Immunol Baltimore (Baltimore, Md. : 1950)"},{"key":"9875_CR146","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1038\/onc.2012.269","volume":"32","author":"J Bastid","year":"2013","unstructured":"Bastid J, Cottalorda-Regairaz A, Alberici G, Bonnefoy N, Eliaou JF, Bensussan A (2013) ENTPD1\/CD39 is a promising therapeutic target in oncology. Oncogene 32:1743\u20131751. https:\/\/doi.org\/10.1038\/onc.2012.269","journal-title":"Oncogene"},{"key":"9875_CR147","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41581-020-0304-7","volume":"16","author":"KM Dwyer","year":"2020","unstructured":"Dwyer KM, Kishore BK, Robson SC (2020) Conversion of extracellular ATP into adenosine: a master switch in renal health and disease. Nat Rev Nephrol 16:509\u2013524. https:\/\/doi.org\/10.1038\/s41581-020-0304-7","journal-title":"Nat Rev Nephrol"},{"key":"9875_CR148","doi-asserted-by":"publisher","first-page":"e18704","DOI":"10.1371\/journal.pone.0018704","volume":"6","author":"W Yu","year":"2011","unstructured":"Yu W, Robson SC, Hill WG (2011) Expression and distribution of ectonucleotidases in mouse urinary bladder. PLoS ONE 6:e18704. https:\/\/doi.org\/10.1371\/journal.pone.0018704","journal-title":"PLoS ONE"},{"key":"9875_CR149","doi-asserted-by":"publisher","first-page":"5288","DOI":"10.1096\/fj.14-255885","volume":"28","author":"W Yu","year":"2014","unstructured":"Yu W, Sun X, Robson SC, Hill WG (2014) ADP-induced bladder contractility is mediated by P2Y12 receptor and temporally regulated by ectonucleotidases and adenosine signaling. FASEB J 28:5288\u20135298. https:\/\/doi.org\/10.1096\/fj.14-255885","journal-title":"FASEB J"},{"key":"9875_CR150","doi-asserted-by":"publisher","first-page":"28629","DOI":"10.1074\/jbc.M114.604082","volume":"289","author":"G Kauffenstein","year":"2014","unstructured":"Kauffenstein G, Pelletier J, Lavoie EG, Kukulski F, Mart\u00edn-Satu\u00e9 M, Dufresne SS, Frenette J, Ribas F\u00fcrstenau C, Sereda MJ, Toutain B, Henrion D, Sullivan R, Vial C, S\u00e9vigny J (2014) Nucleoside triphosphate diphosphohydrolase-1 ectonucleotidase is required for normal vas deferens contraction and male fertility through maintaining P2X1 receptor function*. J Biol Chem 289:28629\u201328639. https:\/\/doi.org\/10.1074\/jbc.M114.604082","journal-title":"J Biol Chem"},{"key":"9875_CR151","doi-asserted-by":"publisher","unstructured":"Ferreira JM, Matheus LHG, Almeida RVSd, Melo PAdS, Leite KRM, Murta CB, Claro JFdA, Camacho CP, Pontes-J\u00fanior J, Dell\u00ea H (2021) High CD39 expression is associated with the non-muscle-invasive phenotype of human bladder cancer. Oncotarget 12(16):1580\u20131586. https:\/\/doi.org\/10.18632\/oncotarget.28029","DOI":"10.18632\/oncotarget.28029"},{"key":"9875_CR152","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11302-018-9642-3","volume":"15","author":"CFF Gardani","year":"2019","unstructured":"Gardani CFF, Cappellari AR, de Souza JB, da Silva BT, Engroff P, Moritz CEJ, Scholl JN, Battastini AMO, Figueir\u00f3 F, Morrone FB (2019) Hydrolysis of ATP, ADP, and AMP is increased in blood plasma of prostate cancer patients. Purinergic Signalling 15:95\u2013105. https:\/\/doi.org\/10.1007\/s11302-018-9642-3","journal-title":"Purinergic Signalling"},{"key":"9875_CR153","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.biopha.2012.12.004","volume":"67","author":"V Battisti","year":"2013","unstructured":"Battisti V, Maders LDK, Bagatini MD, Battisti IE, Bell\u00e9 LP, Santos KF, Maldonado PA, Thom\u00e9 GR, Schetinger MRC, Morsch VM (2013) Ectonucleotide pyrophosphatase\/phosphodiesterase (E-NPP) and adenosine deaminase (ADA) activities in prostate cancer patients: influence of Gleason score, treatment and bone metastasis. Biomed Pharmacother 67:203\u2013208. https:\/\/doi.org\/10.1016\/j.biopha.2012.12.004","journal-title":"Biomed Pharmacother"},{"key":"9875_CR154","unstructured":"Plavix\/Clopidogrel bisulfate Drug Approval Package (1997) U. S. Food & Drug Administration. www.accessdata.fda.gov\/drugsatfda_docs\/nda\/97\/020839_plavix_toc.cfm. Accessed 24 Nov\u00a02020"},{"key":"9875_CR155","unstructured":"The safety and efficacy of gefapixant (AF-219\/MK-7264) in female subjects with interstitial cystitis bladder pain syndrome. ClinicalTrials.gov identifier: NCT01569438. Updated 17 August 2020.  https:\/\/ClinicalTrials.gov\/show\/NCT01569438"},{"key":"9875_CR156","unstructured":"A four-week multicenter study evaluating the safety and efficacy of gefapixant (AF-219\/MK-7264) in subjects with osteoarthritis of the knee. ClinicalTrials.gov identifier: NCT01554579. Updated  27 June 2019.https:\/\/ClinicalTrials.gov\/show\/NCT01554579"},{"key":"9875_CR157","unstructured":"Efficacy and safety of gefapixant (MK-7264) in women with chronic cough and stress Urinary Incontinence (MK-7264-042). ClinicalTrials.gov identifier: NCT04193176. Updated  26 April 2022. https:\/\/ClinicalTrials.gov\/show\/NCT04193176"},{"key":"9875_CR158","unstructured":"A Randomised, Placebo-controlled, Double-blind Trial of the Antidepressant Efficacy of a Novel CNS-penetrant P2X7 Receptor Antagonist, JNJ-54175446, in People With Major Depressive Disorder, an Incomplete Response to Monoaminergic Antidepressant Drugs, and a Biomarker Profile Predictive of Active P2X7 Signalling. ClinicalTrials.gov identifier: NCT04116606. Updated 11 May 2022.https:\/\/ClinicalTrials.gov\/show\/NCT04116606"},{"key":"9875_CR159","unstructured":"A PHASE 2A, Randomized, double-blind, placebo-controlled, parallel-group study of CE-224,535, an antagonist of the P2X7 receptor, in the treatment of the signs and symptoms of rheumatoid arthritis in subjects who are inadequately controlled on Methotrexate.  ClinicalTrials.gov identifier: NCT00628095. Updated  April 2022. https:\/\/ClinicalTrials.gov\/show\/NCT00628095"},{"key":"9875_CR160","unstructured":"A Randomised, Double-Blind (With Open Comparator Etanercept Limb), Placebo-Controlled, Phase IIb, Multicentre Study to Evaluate the Efficacy of 4 Doses of AZD9056 Administered for 6 Months on the Signs and Symptoms of Rheumatoid Arthritis in Patients With Active Disease Receiving Background Methotrexate or Sulphasalazine. ClinicalTrials.gov identifier: NCT00520572. Updated  February 2013. https:\/\/ClinicalTrials.gov\/show\/NCT00520572"},{"key":"9875_CR161","unstructured":"A First-Time-in-Human Randomised, Single Blind Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics, of Single Escalating Doses of GSK1482160, in Male and Female Healthy Subjects, and to Make a Preliminary Assessment of the Effect of Food. ClinicalTrials.gov identifier: NCT00849134. Updated 7 July 2017.  https:\/\/ClinicalTrials.gov\/show\/NCT00849134"},{"key":"9875_CR162","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1365-2125.2012.04320.x","volume":"75","author":"Z Ali","year":"2013","unstructured":"Ali Z, Laurijssens B, Ostenfeld T, McHugh S, Stylianou A, Scott-Stevens P, Hosking L, Dewit O, Richardson JC, Chen C (2013) Pharmacokinetic and pharmacodynamic profiling of a P2X7 receptor allosteric modulator GSK1482160 in healthy human subjects. Br J Clin Pharmacol 75:197\u2013207. https:\/\/doi.org\/10.1111\/j.1365-2125.2012.04320.x","journal-title":"Br J Clin Pharmacol"},{"key":"9875_CR163","unstructured":"A Double-Blind, Placebo-Controlled, Randomized Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-55308942 in Healthy Male and Female Subjects. ClinicalTrials.gov identifier: NCT03151486. Updated 19 April 2018 https:\/\/ClinicalTrials.gov\/show\/NCT03151486"},{"key":"9875_CR164","unstructured":"An Open-Label Phase 1 Investigation of the Safety and Tolerability of BSCT (Anti-nf-P2X7) 10% Ointment When Applied Twice Daily for 28 Days in Male and Female Patients With Basal Cell Carcinoma. ClinicalTrials.gov identifier: NCT002587819. Updated 4 April 2016. https:\/\/ClinicalTrials.gov\/show\/NCT02587819"},{"key":"9875_CR165","unstructured":"An Open-label PET Study to Investigate P2X7 Receptor Occupancy by JNJ-55308942 Using [18F]-JNJ-64413739. ClinicalTrials.gov identifier: NCT03437590. Updated 23 January 2019 https:\/\/ClinicalTrials.gov\/show\/NCT03437590)"},{"key":"9875_CR166","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/bjd.15364","volume":"177","author":"SM Gilbert","year":"2017","unstructured":"Gilbert SM, Gidley Baird A, Glazer S, Barden JA, Glazer A, Teh LC, King J (2017) A phase I clinical trial demonstrates that nfP2X(7) -targeted antibodies provide a novel, safe and tolerable topical therapy for basal cell carcinoma. Br J Dermatol 177:117\u2013124. https:\/\/doi.org\/10.1111\/bjd.15364","journal-title":"Br J Dermatol"},{"key":"9875_CR167","unstructured":"A Multi-Center, Parallel Group, Double-Masked, Randomized, Placebo-Controlled Study of Multiple Ocular Instillations of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease. ClinicalTrials.gov identifier: NCT00403975. Updated  22 February 2016. https:\/\/ClinicalTrials.gov\/show\/NCT00403975"},{"key":"9875_CR168","unstructured":"A Multi-Center, Parallel-Group, Double-Masked, Randomized, Placebo-Controlled Study of the Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% and Placebo in Subjects With Dry Eye Disease. ClinicalTrials.gov identifier: NCT02116010. Updated 9 January 2015.https:\/\/ClinicalTrials.gov\/show\/NCT00600288)"},{"key":"9875_CR169","unstructured":"A Multi-Center, Double-Masked, Randomized, Placebo-Controlled, Dose-Ranging Study of Multiple Ocular Instillations of INS365 Ophthalmic Solution vs. Placebo in Subjects With Dry Eye Disease. ClinicalTrials.gov identifier: NCT00404131. Updated 29 November 2016https:\/\/ClinicalTrials.gov\/show\/NCT00404131)"},{"key":"9875_CR170","unstructured":"SDouble-Masked, Randomized, Placebo-Controlled Study of Efficacy Parameter Following Administration of INS365 Ophthalmic Solution or Placebo in a Controlled Adverse Environment (CAE) Chamber in Subjects With Non-Sjogren's Associated Dry Eye. ClinicalTrials.gov identifier: NCT00037661. Updated 2 October 2015.  (https:\/\/ClinicalTrials.gov\/show\/NCT00037661)"},{"key":"9875_CR171","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s12886-018-0910-3","volume":"18","author":"Y Mun","year":"2018","unstructured":"Mun Y, Kwon J-W, Oh JY (2018) Therapeutic effects of 3% diquafosol ophthalmic solution in patients with short tear film break-up time-type dry eye disease. BMC Ophthalmol 18:237\u2013237. https:\/\/doi.org\/10.1186\/s12886-018-0910-3","journal-title":"BMC Ophthalmol"},{"key":"9875_CR172","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ajo.2015.12.002","volume":"163","author":"DH Park","year":"2016","unstructured":"Park DH, Chung JK, Seo DR, Lee SJ (2016) Clinical effects and safety of 3% diquafosol ophthalmic solution for patients with dry eye after cataract surgery: a randomized controlled trial. Am J Ophthalmol 163:122-131.e122. https:\/\/doi.org\/10.1016\/j.ajo.2015.12.002","journal-title":"Am J Ophthalmol"},{"key":"9875_CR173","unstructured":"A Phase 3, International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis Lung Disease and FEV1 Greater Than or Equal to 75% Predicted But Less Than or Equal to 110% Predicted.  ClinicalTrials.gov identifier: NCT00625612. Updated 1 November 2015 https:\/\/ClinicalTrials.gov\/show\/NCT00625612)"},{"key":"9875_CR174","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jcf.2012.05.003","volume":"11","author":"F Ratjen","year":"2012","unstructured":"Ratjen F, Durham T, Navratil T, Schaberg A, Accurso FJ, Wainwright C, Barnes M, Moss RB (2012) Long term effects of denufosol tetrasodium in patients with cystic fibrosis. J Cyst Fibros 11:539\u2013549. https:\/\/doi.org\/10.1016\/j.jcf.2012.05.003","journal-title":"J Cyst Fibros"},{"key":"9875_CR175","doi-asserted-by":"publisher","unstructured":"de Baaij JH, Kompatscher A, Viering DH, Bos C, Bindels RJ, Hoenderop JG (2016) P2X6 knockout mice exhibit normal electrolyte homeostasis. PLoS ONE 11:e0156803. https:\/\/doi.org\/10.1371\/journal.pone.0156803","DOI":"10.1371\/journal.pone.0156803"},{"key":"9875_CR176","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/s1566-0702(01)00319-8","volume":"92","author":"C Vial","year":"2001","unstructured":"Vial C, Evans RJ (2001) Smooth muscle does not have a common P2X receptor phenotype: expression, ontogeny and function of P2x1 receptors in mouse ileum, bladder and reproductive systems. Auton Neurosci\u202f: Basic Clin 92:56\u201364. https:\/\/doi.org\/10.1016\/s1566-0702(01)00319-8","journal-title":"Auton Neurosci : Basic Clin"},{"key":"9875_CR177","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.fertnstert.2009.02.061","volume":"93","author":"FC Banks","year":"2010","unstructured":"Banks FC, Calvert RC, Burnstock G (2010) Changing P2X receptor localization on maturing sperm in the epididymides of mice, hamsters, rats, and humans: a preliminary study. Fertil Steril 93:1415\u20131420. https:\/\/doi.org\/10.1016\/j.fertnstert.2009.02.061","journal-title":"Fertil Steril"},{"key":"9875_CR178","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1038\/s41598-018-20216-4","volume":"8","author":"W Yu","year":"2018","unstructured":"Yu W, Hill WG, Robson SC, Zeidel ML (2018) Role of P2X4 receptor in mouse voiding function. Sci Rep 8:1838. https:\/\/doi.org\/10.1038\/s41598-018-20216-4","journal-title":"Sci Rep"},{"key":"9875_CR179","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1111\/j.1464-410X.2008.08337.x","volume":"103","author":"SO Suadicani","year":"2009","unstructured":"Suadicani SO, Urban-Maldonado M, Tar MT, Melman A, Spray DC (2009) Effects of ageing and streptozotocin-induced diabetes on connexin43 and P2 purinoceptor expression in the rat corpora cavernosa and urinary bladder. BJU Int 103:1686\u20131693. https:\/\/doi.org\/10.1111\/j.1464-410X.2008.08337.x","journal-title":"BJU Int"},{"key":"9875_CR180","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1172\/JCI24086","volume":"115","author":"ECY Wang","year":"2005","unstructured":"Wang ECY, Lee J-M, Ruiz WG, Balestreire EM, von Bodungen M, Barrick S, Cockayne DA, Birder LA, Apodaca G (2005) ATP and purinergic receptor\u2013dependent membrane traffic in bladder umbrella cells. J Clin Investig 115:2412\u20132422. https:\/\/doi.org\/10.1172\/JCI24086","journal-title":"J Clin Investig"},{"key":"9875_CR181","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1111\/jcmm.13520","volume":"22","author":"NN Guan","year":"2018","unstructured":"Guan NN, Sharma N, Hall\u00e9n-Grufman K, Jager EWH, Svennersten K (2018) The role of ATP signalling in response to mechanical stimulation studied in T24 cells using new microphysiological tools. J Cell Mol Med 22:2319\u20132328. https:\/\/doi.org\/10.1111\/jcmm.13520","journal-title":"J Cell Mol Med"},{"key":"9875_CR182","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1464-410X.2007.07286.x","volume":"101","author":"M Shabbir","year":"2008","unstructured":"Shabbir M, Ryten M, Thompson C, Mikhailidis D, Burnstock G (2008) Purinergic receptor-mediated effects of ATP in high-grade bladder cancer. BJU Int 101:106\u2013112. https:\/\/doi.org\/10.1111\/j.1464-410X.2007.07286.x","journal-title":"BJU Int"}],"container-title":["Purinergic Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-022-09875-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11302-022-09875-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-022-09875-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T23:47:28Z","timestamp":1744156048000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11302-022-09875-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,10]]},"references-count":182,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["9875"],"URL":"https:\/\/doi.org\/10.1007\/s11302-022-09875-1","relation":{},"ISSN":["1573-9538","1573-9546"],"issn-type":[{"value":"1573-9538","type":"print"},{"value":"1573-9546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,10]]},"assertion":[{"value":"18 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}